Pliant Therapeutics Inc

Pliant Therapeutics Inc(PLRX)價格預測

$0.806

-0.009 (-1.16%)收盤時

價格預測

1-Day Price Prediction
-0.70%
1-Week Prediction
-3.53%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

PLRX 相似圖表分析預測

Alphio's PLRX stock price prediction model matches the current Pliant Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.80 (-0.70%). The 1-week path is $0.78 (-3.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Pliant Therapeutics Inc 股票嗎?

Pliant Therapeutics Inc is currently trading at $0.8392, which is very close to its 52-week low of $0.83. The RSI is at 30.592, indicating that the stock is oversold, but the company continues to report significant losses, with a net income loss of $23.577 million in Q4 2025. While there are some positive developments in their oncology focus, the overall financial performance and recent stock decline suggest caution. The main risk is the company's ongoing negative earnings, with an EPS of -0.36 reported last quarter, which raises concerns about its profitability moving forward.

PLRX 股價於 Friday 收在 $0.81,此前下跌 -1.16%

Pliant Therapeutics Inc (PLRX) last closed at $0.8063, losing -1.16%. These facts feed the 1-day and 1-week PLRX price prediction above.

預測驅動因素

Pliant Therapeutics Inc(PLRX)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 PLRX 最接近的股票,依相似度排序。

PLRX 季節性分析

Historically the probability of a positive November return for PLRX is 0.00%. January offers the highest probability of a positive month at 37.70%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易